Highlights Lifecore Biomedical, Inc.

Equities

LFCR

US5147661046

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-21 EDT			5-day change	1st Jan Change
5.02 ^USD	-1.57%		-3.46%	-18.90%

06-11	22NW Fund Submits Shareholder Proposals to Lifecore Biomedical	CI
05-20	22NW Fund Nominates Candidates to the Board of Lifecore Biomedical	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Lifecore Biomedical, Inc. Engages BDO USA, P.C. as Independent Registered Public Accounting Firm	04-30	CI
Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report	04-19	MT
Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024	04-01	CI
Top Midday Decliners	03-20	MT
Tranche Update on Lifecore Biomedical, Inc.'s Equity Buyback Plan announced on July 14, 2010.	03-20	CI
Global markets live: Merck, Honda, Novartis, Boeing, Nvidia...	01-08
Alcon, Lifecore Biomedical Extend Contract Manufacturing Agreement	01-05	MT
Lifecore Biomedical, Inc. Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements	01-05	CI
Lifecore Biomedical Enters Into Co-Marketing Partnership With SHL Medical	23-10-17	MT
SHL Medical and Lifecore Biomedical Enter Co-Marketing Partnership Agreement	23-10-17	CI
Lifecore Biomedical Releases Update on Timing of Delayed Filings, Development Portfolio	23-10-10	MT
Earnings Flash (LFCR) LIFECORE BIOMEDICAL Reports Q4 Revenue $31.5M	23-08-31	MT
Lifecore Biomedical, Inc. Reports Earnings Results for the Full Year Ended May 28, 2023	23-08-31	CI
Lifecore Biomedical, Inc. Reports Earnings Results for the Fourth Quarter Ended May 28, 2023	23-08-31	CI
Lifecore Biomedical Gets Nasdaq Warning Over Delayed Annual Report	23-08-22	MT
Tranche Update on Lifecore Biomedical, Inc.'s Equity Buyback Plan announced on July 14, 2010.	23-06-02	CI
Lifecore Biomedical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 26, 2023	23-06-01	CI
North American Morning Briefing : Retail Sales, -2-	23-05-16	DJ
Lifecore Biomedical Completes Sale of Curation Foods' O Olive Oil and Vinegar Business for About $6.2 Million	23-04-10	MT
An unknown buyer acquired Remaining Curation Foods segment business of Lifecore Biomedical, Inc. for $6.2 million.	23-04-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Lifecore Biomedical, Inc.

Equities

LFCR

US5147661046

Highlights

Filters